Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s):  BVAXF

Healthcare Biotechnology
BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:BIOV)

BioVaxys Secures GMP-Grade Lipid Supply for Production of DPX-Based Vaccines in Advance of Preclinical and Clinical Program Ramp-Up

PR Newswire 6 days ago

BIOVAXYS ANNOUNCES CLOSING OF FIRST TRANCHE OF PRIVATE PLACEMENT AND ANNOUNCES DEBT SETTLEMENT AGREEMENT

Canada NewsWire 9 days ago

BIOVAXYS ANNOUNCES REPRICING OF PRIVATE PLACEMENT OFFERING

Canada NewsWire 12 days ago

BioVaxys Shares New Data on its DPX(TM) Immune Educating Platform at Personalized Cancer Vaccine Summit

Canada NewsWire December 5, 2024

BIOVAXYS PARTNER SPAYVAC FOR WILDLIFE, INC., SCALES-UP VACCINE PRODUCTION CAPACITY

PR Newswire November 20, 2024

BioVaxys and SpayVac expand vaccine production in Madison

Jocelyn Aspa November 20, 2024

BioVaxys to Participate in the US Government Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) Vaccine Development Consortium

PR Newswire November 5, 2024

BioVaxys' DPX outperforms traditional antigen delivery systems

Jocelyn Aspa October 31, 2024

BioVaxys' DPX Exhibits Superior Immune System Activation Compared to Aqueous and Emulsion-Based Antigen Delivery Systems

PR Newswire October 31, 2024
View More News ››

Opinion & Analysis (CSE:BIOV)

How BioVaxys' DPX platform creates anti-cancer immune response

Research October 8, 2024

Revolutionizing immunotherapies with groundbreaking DPX platform

Lyndsay Malchuk July 30, 2024

Unique Value-Added Antiviral Vaccine Technology Platform

Dave Jackson September 15, 2021
View More Opinion ››

Bullboard Posts (CSE:BIOV)

RE:RE:Asks were at .07 at close Last trades at close CDN

The DPX lipid delivery platform doesn't necessarily need to have a complicated onboard biomolecular cargo to stimulate a strong...
javaman12 - 1 day ago

RE:Asks were at .07 at close Last trades at close CDN

It's good to see the share price moving again in the right direction! Recently, there has been a huge volume in the buying of...
javaman12 - 1 day ago

Asks were at .07 at close Last trades at close CDN

Time ET Ex Price Change Volume Buyer Seller 15:59:15 ...
frankman - 2 days ago

2.3 mil shares traded 1 mil $US OTC .065

Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr ATS ...
frankman - 2 days ago

1.7 mil shares traded (1/2 day) / $US OTC BVAXF 800k~ .065

Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr ATS ...
frankman - 3 days ago

RE:RE:I still expect 50 to 100 percent increase in stock rice

Hideaway absolutely agree. In the early days though they did have temporary corroboration with Merck. They only had two vaccines then...
frankman - 3 days ago
View more Bullboard ››

G Mining Ventures Corp.

G Mining Ventures Corp.

G Mining Ventures Corp. is a Canada-based intermediate gold producer. The Company is engaged in the acquisition, exploration ...
View More »